Zobrazeno 1 - 10
of 1 731
pro vyhledávání: '"he4"'
Autor:
Chunchun Jin, Meifang Deng, Yanling Bei, Chan Zhang, Shiya Wang, Shun Yang, Lvhuan Qiu, Xiuyan Liu, Qiuxiang Chen
Publikováno v:
BMC Medical Imaging, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background Ovarian cancer remains a leading cause of death among women, largely due to its asymptomatic early stages and high mortality when diagnosed late. Early detection significantly improves survival rates, and the Ovarian-Adnexal Repor
Externí odkaz:
https://doaj.org/article/9a1bf2227e9b4e939dfc3fc5cd53bb40
Autor:
Yousra Guelzim, Abdallah Bennasser, Salma Marrakchi, Abdelkader Sqalli Houssaini, Salwa Idoubba, Ismail Boujida, Ahmed Jahid, Nazik Allali, Latifa Chat, Siham El Haddad
Publikováno v:
Radiology Case Reports, Vol 19, Iss 7, Pp 2585-2589 (2024)
Demons-Meigs syndrome is a very rare entity. It combines a benign ovarian “fibroma-like” tumor with ascites and hydrothorax. The notion of benignancy is the key point. CA-125 levels are most of the time normal, but high levels can be observed in
Externí odkaz:
https://doaj.org/article/3f8586145373458d8f427a79ab4ba8b9
Autor:
Tian, Huiqun, Chen, Li ⁎
Publikováno v:
In Journal of Holistic Integrative Pharmacy December 2024 5(4):291-298
Autor:
Mi Tian, Xiaohui Zhu, Lijun Ren, Xuan Zhou, Lina GU, Kaifang Meng, Yaqiong Tian, Hourong Cai, Xiaoqin Liu, Jingjing Ding
Publikováno v:
European Journal of Medical Research, Vol 29, Iss 1, Pp 1-11 (2024)
Abstract Idiopathic pulmonary fibrosis (IPF) is a life-threatening interstitial lung disease. Identifying biomarkers for early diagnosis is of great clinical importance. The epididymis protein 4 (HE4) is important in the process of inflammation and f
Externí odkaz:
https://doaj.org/article/794993b31d7b4897a82e510aeb5f0876
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
ObjectivesWe have recently described a predictive/prognostic model for ovarian cancer, exploiting commonly available clinico-pathological parameters and the ovarian serum biomarkers mesothelin (MSL), human epididymis protein 4 (HE4) and cancer-antige
Externí odkaz:
https://doaj.org/article/873b6b4c10074685a436fd6ef131c495
Autor:
Nur Nadiah Abdul Rashid, Mohd Hamzah Mohd Nasir, Nurasyikin Hamzah, Che Muhammad Khairul Hisyam Ismail, Siti Aishah Sufira Nor Hishamuddin, Izzat Fahimuddin Mohamed Suffian, Azzmer Azzar Abdul Hamid
Publikováno v:
Journal of Tropical Life Science, Vol 14, Iss 2, Pp 331 – 348-331 – 348 (2024)
The Human Epididymis Protein 4 (HE4) biomarker has been extensively investigated for its potential in diagnosing ovarian cancer (OC). For the application of diagnostic techniques and drug delivery, it is crucial to understand the protein tertiary str
Externí odkaz:
https://doaj.org/article/80b7028b40294fcbaa9f4aa78c2c001e
Autor:
Devarajappa Gari Bindu, Kopparapu Venkata Nanda Kumar, Kasireddy Likitha Reddy, Mekala Siva Charani, Yaraganti Gowthami
Publikováno v:
Asian Pacific Journal of Cancer Biology, Vol 9, Iss 1, Pp 81-85 (2024)
Ovarian cancer, with its asymptomatic early stages, poses a significant challenge for early diagnosis and survival improvement. The utilization of tumor markers, including CA -125 and HE4 has become crucial in detecting these silent killers. Addition
Externí odkaz:
https://doaj.org/article/7683350657aa4eeda013d3371abb987c
Autor:
Renáta Sütő, Marianna Pócsi, Zsolt Szabó, Zsolt Fejes, Gergely Ivády, György Kerekes, Miklós Fagyas, Attila Nagy, Zoltán Szentkereszty, János Kappelmayer, Béla Nagy
Publikováno v:
BMC Pulmonary Medicine, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background We retrospectively analyzed serum level of human epididymis protein 4 (HE4) as a pulmonary inflammatory biomarker in patients with COVID-19 pneumonia in association with disease severity and outcome. Methods Ninety-nine (40 critic
Externí odkaz:
https://doaj.org/article/e43e120fd23049329ea3525d6e10d89c
Autor:
Michel Fabbro, Pierre-Jean Lamy, Célia Touraine, Anne Floquet, Isabelle Ray-Coquard, Caroline Mollevi
Publikováno v:
Frontiers in Oncology, Vol 13 (2024)
HE4 and CA-125 are used for epithelial ovarian cancer (EOC) screening, diagnosis, and follow-up. Our objective was to study HE4 and CA-125 kinetics in patients treated for recurrent EOC. Serum samples were prospectively collected before the first che
Externí odkaz:
https://doaj.org/article/37769d66d27546e0a6ad6cc5ca66196e
Publikováno v:
Obstetrics & Gynecology Science, Vol 66, Iss 4, Pp 290-299 (2023)
Objective We evaluated the usefulness of human epididymis protein 4 (HE4), a tumor marker, during and after treatment in patients with ovarian cancer (OC). Methods We included Japanese patients newly diagnosed with OC treated at the National Cancer C
Externí odkaz:
https://doaj.org/article/ec1d1db9bb4d4e4a9191622308b6b24d